Displaying items by tag: Division of Pulmonary, Allergy and Critical Medicine

UAB’s Mark Dransfield has been elected to the American Society for Clinical Investigation, an honor society for physician-scientists who have made significant contributions to better understanding of human disease.
UAB has created the only comprehensive interventional pulmonary medicine program in Alabama to better diagnose and treat lung and chest diseases.
In another example of precision medicine, UAB researchers have used IPF patients own lung tissue to create models to determine the most effective medication for that patient.
Five faculty members in the School of Medicine have been named the 2016 class of James A. Pittman Jr., M.D., Scholars, a program organized to recognize the contributions of junior faculty and support the retention of highly competitive scientists and physician-scientists.
The winners of the first SPARC competition, an initiative between UAB Medicine and Medscape, will share $40,000 in grants for quality improvement projects.
A new national, multisite study, chaired by a UAB pulmonologist, shows that supplemental oxygen does not reduce mortality or hospitalization for COPD patients with moderately low levels of blood oxygen.
Moon Nahm’s research has led to improvements in testing effectiveness of pneumonia vaccines, a key step to preventing deaths from S. pneumoniae, the leading cause of pneumonia estimated to kill 1.6 million children annually.
Exacerbations of COPD, particularly mild COPD, lead to a decline in lung function in smokers, according to new research from UAB.
Ben Vaughan Branscomb, M.D., a pioneering pulmonologist and professor at the University of Alabama at Birmingham for 51 years, passed away July 4. Branscomb, 92, was often referred to as the father of pulmonary medicine.
Page 5 of 9